Table 4 Effect of the exposure to the POINCARE-2 strategy on vital status at Day60 according to the main cause of admission

1.41

0.92–2.2

0.113

1.39

0.82–2.4

0.226

1.49

1.05–2.1

0.027

1.42

0.90–2.2

0.128

0.83

0.47–1.4

0.524

0.62

0.30–1.2

0.174

0.98

0.63–1.5

0.922

0.79

0.45–1.4

0.408

1.64

1.00–2.7

0.047

1.78

0.85–3.8

0.126

1.55

1.02–2.4

0.041

1.45

0.79–2.7

0.230

1.96

1.19–3.2

0.007

0.93

0.46–1.9

0.829

2.03

1.33–3.1

0.001

1.01

0.55–1.8

0.980